Criteria for placement of drug in Schedule V

50-32-231 . Criteria for placement of drug in Schedule V. The board shall place a drug in Schedule V if it finds that: (1) the drug has low potential for abuse relative to the controlled drugs listed in Schedule IV; (2) the drug has currently accepted medical use in treatment in the United States; and (3) the drug has limited physical dependence or psychological dependence liability relative to the dangerous drugs listed in Schedule IV.